Brachytherapy
Volume 7, Issue 1 , Pages 50-54 , January 2008

Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung

  • Mark G. Trombetta

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, USA. Tel.: +1-412-359-3400; fax: +1-412-359-3981.
    • ,
  • Athanasios Colonias

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Daryl Makishi

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Robert Keenan

      Affiliations

    • Division of Thoracic Surgery, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • E. Day Werts

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA
    • ,
  • Rodney Landreneau

      Affiliations

    • Division of Thoracic Surgery, University of Pittsburgh Medical Center; Shadyside, Pittsburgh, PA
    • ,
  • David S. Parda

      Affiliations

    • Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA

Received 27 March 2007 ,Revised 7 October 2007 ,Accepted 8 November 2007.

References 

  1. Chen A, Galloway M, Landreneau R, et al. Intraoperative 125 Iodine brachytherapy for high risk non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys. 1999;44(5):1057–1063
  2. Ginsberg RJ, Martini N, Zaman M, et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumors. Ann Thorac Surg. 1994;57(6):1440–1445
  3. Nori D, Li A, Pugkem T, et al. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected Stage III non-small cell lung cancer with positive margin: A pilot study. J Surg Oncol. 1995;60:257–261
  4. Hilaris B. Lung brachytherapy an overview and current indications. Chest Surg Clin N Am. 1994;4(1):
  5. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125I brachytherapy after sublobar resection in high risk patients with Stage I non-small cell lung cancer. Surgery. 2004;134(4):691–697
  6. Tallman M, Williams J, Eagleton M, et al. Tolerance of normal rabbit femoral arteries to single high dose external beam irradiation. Cardiovasc Radiat Med. 1999;1(2):131–137
  7. Mittal B, Pelzer H, Tsao C, et al. Intraoperative radiation of canine carotid artery, internal jugular vein, and vagus nerve. Arch Otolaryngol Head Neck Durg. 1990;116:1425–1430
  8. de Boer W, Mehta D, Timens W, et al. The short and long term effects of intraoperative electron beam radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45(2):501–506
  9. Mannerts G, Martijin H, Crommelin M, et al. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys. 1999;45(2):297–308
  10. Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-flurouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum. 1996;39:1379–1395
  11. Werber Jl, Sood B, Alfieri A, et al. Tolerance of the carotid sheath contents to brachytherapy: An experimental study. Laryngoscope. 1991;101(6 pt 1):587–591
  12. ACOSOG Z4032. A randomized phase III study of sublobar resection versus sublobar resection plus brachytherapy in high risk patients with non small cell lung cancer (NSCLC) 3 cm. or smaller.
  13. Ginsberg RJ, Rubenstein LV, Benfield J, et al. Lung Cancer Study Group Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615–623
  14. Lewis JW, Ajlouni M, Kavle PA, et al. Role of brachytherapy in management of pulmonary and mediastinal malignancies. Ann Thorac Surg. 1990;49(5):728–733
  15. Dosoretz DE, Katin MJ, Blitzer PH, et al. Medically inoperable lung carcinoma: The role of radiation therapy. Semin Radiat Oncol. 1996;6:98–104
  16. Krol ADG, Aussems P, Noordijk EM, et al. Local radiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys. 1996;34(2):297–302
  17. Sibley GS, Jamieson TA, Marks LB, et al. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys. 1998;40(1):149–150
  18. VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: Part 2, initial clinical experience—Technical and multidisciplinary considerations in 30 patients. Am J Roentgenol. 2005;184(2):381–390
  19. Fernando HC, Hoyos AD, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. Thorac Cardiovasc Surg. 2005;129(3):639–644
  20. Timmerman R, McGarry R, Papiez L, et al. Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;63(S1):S99;(abstr 164).
  21. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma. Cancer. 2004;101(7):1623–1631

PII: S1538-4721(07)00281-4

doi: 10.1016/j.brachy.2007.11.003

Brachytherapy
Volume 7, Issue 1 , Pages 50-54 , January 2008

Article Tools

* Image Usage & Resolution